Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization NBIX - Neurocrine Biosciences, Inc.
-2.7 M
LAST VALUE
-8.31%
2 YEAR CAGR
-6.38%
5 YEAR CAGR
-15.61%
10 YEAR CAGR